Catalyst Pharmaceuticals (CPRX) EPS Estimated At $-0.06; Franklin Resources Lifted By $2.86 Million Its Canadian Nat Res LTD (CNQ) Position

July 20, 2017 - By Stephen Andrade

Analysts expect Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) to report $-0.06 EPS on August, 8.They anticipate $0.00 EPS change or 0.00% from last quarter’s $-0.06 EPS. After having $-0.06 EPS previously, Catalyst Pharmaceuticals Inc’s analysts see 0.00% EPS growth. The stock increased 9.74% or $0.26 during the last trading session, reaching $2.93. About shares traded. Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) has risen 267.48% since July 20, 2016 and is uptrending. It has outperformed by 250.78% the S&P500.

Franklin Resources Inc increased Canadian Nat Res Ltd (CNQ) stake by 2.58% reported in 2016Q4 SEC filing. Franklin Resources Inc acquired 92,268 shares as Canadian Nat Res Ltd (CNQ)’s stock rose 3.36%. The Franklin Resources Inc holds 3.67M shares with $116.96M value, up from 3.58M last quarter. Canadian Nat Res Ltd now has $37.62 billion valuation. The stock increased 1.84% or $0.55 during the last trading session, reaching $30.48. About shares traded. Canadian Natural Resource Ltd (USA) (NYSE:CNQ) has risen 10.32% since July 20, 2016 and is uptrending. It has underperformed by 6.38% the S&P500.

Franklin Resources Inc decreased Ishares Inc (IEMG) stake by 6.41M shares to 1.75M valued at $74.26 million in 2016Q4. It also reduced Telefonica S A (NYSE:TEF) stake by 2.87 million shares and now owns 9.89M shares. Netease Inc (NASDAQ:NTES) was reduced too.

Among 14 analysts covering Canadian Natural Resources Limited (NYSE:CNQ), 12 have Buy rating, 0 Sell and 2 Hold. Therefore 86% are positive. Canadian Natural Resources Limited had 27 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Top Pick” rating given on Friday, March 10 by RBC Capital Markets. The stock of Canadian Natural Resource Ltd (USA) (NYSE:CNQ) has “Sector Outperform” rating given on Friday, August 7 by Scotia Capital. JP Morgan downgraded Canadian Natural Resource Ltd (USA) (NYSE:CNQ) on Wednesday, August 26 to “Overweight” rating. The stock of Canadian Natural Resource Ltd (USA) (NYSE:CNQ) earned “Buy” rating by Citigroup on Friday, June 17. Bank of America initiated Canadian Natural Resource Ltd (USA) (NYSE:CNQ) on Friday, August 19 with “Buy” rating. The rating was upgraded by Raymond James on Friday, August 7 to “”. RBC Capital Markets maintained the shares of CNQ in report on Thursday, June 16 with “Buy” rating. The stock has “Hold” rating by TD Securities on Friday, April 1. RBC Capital Markets maintained Canadian Natural Resource Ltd (USA) (NYSE:CNQ) on Friday, November 6 with “Outperform” rating. The stock has “Overweight” rating by Morgan Stanley on Wednesday, July 19.

Among 2 analysts covering Catalyst Pharmaceuticals (NASDAQ:CPRX), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Catalyst Pharmaceuticals had 3 analyst reports since April 26, 2016 according to SRatingsIntel. As per Wednesday, October 5, the company rating was upgraded by PiperJaffray. The firm has “Neutral” rating by Piper Jaffray given on Tuesday, April 26. As per Wednesday, October 5, the company rating was upgraded by Piper Jaffray.

Investors sentiment increased to 0.94 in 2016 Q4. Its up 0.64, from 0.3 in 2016Q3. It increased, as 6 investors sold Catalyst Pharmaceuticals Inc shares while 12 reduced holdings. 9 funds opened positions while 8 raised stakes. 23.81 million shares or 1.65% more from 23.42 million shares in 2016Q3 were reported. Citigroup reported 4,088 shares. Kennedy Capital Mgmt holds 0% or 233,171 shares in its portfolio. Bancorp Of Mellon Corp reported 66,772 shares or 0% of all its holdings. Compton Cap Management Ri holds 0.01% or 10,000 shares in its portfolio. Creative Planning invested in 16,681 shares or 0% of the stock. Credit Suisse Ag has invested 0% in Catalyst Pharmaceuticals Inc (NASDAQ:CPRX). Bancorp Of Montreal Can reported 1,000 shares. Kcg Hldgs Incorporated holds 0% or 54,200 shares. Blackrock Advisors Lc holds 12,442 shares or 0% of its portfolio. Berson And Corrado Advisors Limited Liability Com invested in 190,600 shares or 0.12% of the stock. Vanguard Gru owns 0% invested in Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) for 2.99 million shares. Walleye Trading Ltd Liability Com reported 0% in Catalyst Pharmaceuticals Inc (NASDAQ:CPRX). Weiss Multi reported 68,000 shares. Venbio Select Advisor Limited Liability holds 1.14M shares or 0.24% of its portfolio. Bank Of America Corporation De invested in 1,860 shares or 0% of the stock.